(Q47896024)

6 February 2018

title

Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer (English)

1 reference

6 February 2018

author

Adrian Harris

8

1 reference

6 February 2018

author name string

Van den Eynden GG

1

1 reference

6 February 2018

Van der Auwera I

2

1 reference

6 February 2018

Van Laere S

3

1 reference

6 February 2018

Colpaert CG

4

1 reference

6 February 2018

van Dam P

5

1 reference

6 February 2018

Merajver S

6

1 reference

6 February 2018

Kleer CG

7

1 reference

6 February 2018

Van Marck EA

9

1 reference

6 February 2018

Dirix LY

10

1 reference

6 February 2018

Vermeulen PB

11

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 May 2004

1 reference

6 February 2018

Breast Cancer Research and Treatment

published in

1 reference

6 February 2018

volume

85

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

13-22

1 reference

6 February 2018

Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability

cites work

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

Tissue microarrays for rapid linking of molecular changes to clinical endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Update on the management of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Inflammatory breast cancer: a review

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Biological factors of prognostic significance in locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Estrogen receptors in human breast cancer. 1. Methodology and characterization of receptors

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

WISP3 is a novel tumor suppressor gene of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Persistent E-cadherin expression in inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Tissue microarrays for predictive molecular pathology

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Which breast carcinomas need HER-2/neu gene study after immunohistochemical analysis? Results of combined use of antibodies against different c-erbB2 protein domains

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Influence of tissue heterogeneity on the determination of steroid receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Heterogeneity of intratumour proliferative activity in primary breast cancer: biological and clinical aspects

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Human breast cancer: Heterogeneity of estrogen binding sites

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Breast cancer heterogeneity: evaluation of clonality in primary and metastatic lesions

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Validation of tissue microarray technology in breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

Regulation of E-cadherin: does hypoxia initiate the metastatic cascade?

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021028.33926.A8

7 January 2021

10.1023/B:BREA.0000021028.33926.A8

Identifiers

DOI

1 reference

6 February 2018

Dimensions Publication ID

1034124164

0 references

1 reference

6 February 2018